Geron Corporation
Biotechnology
Healthcare
GERN
666 M shares
NASDAQ US
traded
23 Sep 2025
listed
no
open
1.35
52 week high
4.78
high
1.37
52 week low
0.00
previous Close
1.33
P/E ratio
market cap
723 M
div yield
0
net profit margin
0.00 %
50.00 %
operating incoming
0.00 %
net change in cash
0.00 %
top